Henry Schein Corp - רווח נקי למניה אחת בשנים עשר החודשים האחרונים HSIC

Henry Schein, Inc. is expanding its pharmacy segment through software integration and the acquisition of regional suppliers. Revenues are based on global supplies of medical technology and vaccines, while high liquidity ensures stable cash turnover. The annual change in net income per share over a rolling period demonstrates the dynamics of this growth, where the 15.60 mark serves as a key metric for the indicator's current state.
פילוחי מדדים פיננסיים ומדדי שוק עבור Henry Schein, Inc. (HSIC)

Henry Schein, Inc. ensures global business resilience through diversified supplies of consumables and software for millions of medical practices. By analyzing the YoY EPS dynamics over the last 12 months, an investor can see the real growth rate of earnings per share, which allows them to filter out market noise and determine whether the stock is overvalued based on current expectations relative to its fundamental value.